Dopaminergic neurons protected from degeneration by GDNF gene therapy
- PMID: 9012352
- DOI: 10.1126/science.275.5301.838
Dopaminergic neurons protected from degeneration by GDNF gene therapy
Abstract
Glial cell line-derived neurotrophic factor (GDNF) supports growth and survival of dopaminergic (DA) neurons. A replication-defective adenoviral (Ad) vector encoding human GDNF injected near the rat substantia nigra was found to protect DA neurons from the progressive degeneration induced by the neurotoxin 6-hydroxydopamine (6-OHDA) injected into the striatum. Ad GDNF gene therapy reduced loss of DA neurons approximately threefold 6 weeks after 6-OHDA lesion, as compared with no treatment or injection of Ad lacZ or Ad mGDNF (encoding a biologically inactive deletion mutant GDNF). These results suggest that Ad vector-mediated GDNF gene therapy may slow the DA neuronal cell loss in humans with Parkinson's disease.
Comment in
-
Experiments in a Parkinson's rat model.Science. 1997 Jul 18;277(5324):389-90. doi: 10.1126/science.277.5324.389. Science. 1997. PMID: 9518368 No abstract available.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
